Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA

Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA

Objectives This observational study compares the effectiveness of baricitinib (BARI), a targeted synthetic disease-modifying antirheumatic drug (tsDMARD), with alternative biological DMARDs (bDMARDs) in patients with rheumatoid arthritis (RA), from a prospective, longitudinal cohort.Methods We compa...

Full description

Bibliographic Details
Main Authors: Axel Finckh, Kim Lauper, Denis Mongin, Delphine S Courvoisier, Benoît Thomas P Gilbert, Clémentine Perrier, Romain Aymon, Cédric Laedermann, Ruediger Mueller
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e072300.full

Internet

https://bmjopen.bmj.com/content/14/3/e072300.full

Similar Items